argenx Kicks Off 2025 with Record-Breaking Growth

Previous
Previous

Apellis Pharmaceuticals receives FDA approval of EMPAVELI® (pegcetacoplan)

Next
Next

Big Moves in AI-Driven Oncology: Pathos Secures Major Backing